Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Broad wound microorganisms refer to the diverse community of bacteria, fungi, and other pathogens that colonize and infect cutaneous wounds (Bowler et al., 2001). Common species include Staphylococcus aureus, Pseudomonas aeruginosa, and various anaerobic bacteria, which often coexist in complex biofilms (Percival et al., 2015). These organisms impede the natural healing process by secreting proteases and toxins that damage host tissue and degrade the extracellular matrix (Negut et al., 2018). Their presence triggers a prolonged inflammatory response, leading to chronic wounds and potential systemic infection or sepsis (StatPearls, 2023). Therapeutic interventions target these microorganisms through the use of broad-spectrum antibiotics, topical antiseptics, and physical debridement (Negut et al., 2018). Drugs like silver sulfadiazine and mupirocin are frequently employed to reduce microbial load and prevent the spread of infection (StatPearls, 2023). However, the development of antimicrobial resistance and the protective nature of biofilms pose significant challenges to effective treatment (Percival et al., 2015). Understanding the composition and behavior of these microbial communities is essential for developing targeted therapies that promote tissue regeneration and wound closure (Bowler et al., 2001).
Inhibition of microbial cell wall synthesis, protein synthesis, or DNA replication; disruption of cell membrane integrity; oxidative damage to microbial components.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Broad wound microorganisms.